Aldeyra Therapeutics, Inc. (ALDX) Stock Price, Quote & AI Analysis

Live ALDX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Aldeyra Therapeutics, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Aldeyra Therapeutics, Inc. (ALDX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

ALDX
Aldeyra Therapeutics, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
1.760000
High
1.760000
Low
1.615000
Volume
972,344
VWAP
-
Market Cap
$112,197,186.48
52W Range
$1.07 - $6.18
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 5, 2026 Q2
Market
EPS Estimate: $-0.1377
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Aldeyra Therapeutics, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Aldeyra Therapeutics, Inc. Overview

Company information

Company Overview

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Company Details
Market Cap
$97.72M
Shares Outstanding
60,321,100
Weighted Shares Outstanding
60,321,068
CEO
Todd C. Brady
Address
131 HARTWELL AVENUE, LEXINGTON, MA, 02421
Employees
7
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Aldeyra Therapeutics, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...